These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 19925429)

  • 1. Use of cell lines in the investigation of pharmacogenetic loci.
    Zhang W; Dolan ME
    Curr Pharm Des; 2009; 15(32):3782-95. PubMed ID: 19925429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copy number polymorphisms and anticancer pharmacogenomics.
    Gamazon ER; Huang RS; Dolan ME; Cox NJ
    Genome Biol; 2011; 12(5):R46. PubMed ID: 21609475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci.
    Gamazon ER; Huang RS; Cox NJ; Dolan ME
    Proc Natl Acad Sci U S A; 2010 May; 107(20):9287-92. PubMed ID: 20442332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapy.
    Stark AL; Hause RJ; Gorsic LK; Antao NN; Wong SS; Chung SH; Gill DF; Im HK; Myers JL; White KP; Jones RB; Dolan ME
    PLoS Genet; 2014 Apr; 10(4):e1004192. PubMed ID: 24699359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
    Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
    Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of cancer drugs.
    Hertz DL; Rae J
    Annu Rev Med; 2015; 66():65-81. PubMed ID: 25386932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics discovery and implementation in genome-wide association studies era.
    Ni X; Zhang W; Huang RS
    Wiley Interdiscip Rev Syst Biol Med; 2013; 5(1):1-9. PubMed ID: 23188748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using pharmacogene polymorphism panels to detect germline pharmacodynamic markers in oncology.
    Hertz DL; McLeod HL
    Clin Cancer Res; 2014 May; 20(10):2530-40. PubMed ID: 24831276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of CEPH and non-CEPH lymphoblast cell lines in pharmacogenetic studies.
    Shukla SJ; Dolan ME
    Pharmacogenomics; 2005 Apr; 6(3):303-10. PubMed ID: 16013961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Wide Association Studies of Chemotherapeutic Toxicities: Genomics of Inequality.
    Mapes B; El Charif O; Al-Sawwaf S; Dolan ME
    Clin Cancer Res; 2017 Aug; 23(15):4010-4019. PubMed ID: 28442506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic tests for predicting the toxicity and efficacy of anticancer chemotherapy.
    Mladosievicova B; Carter A; Kristova V
    Neoplasma; 2007; 54(3):181-8. PubMed ID: 17447847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines.
    Niu N; Liu T; Cairns J; Ly RC; Tan X; Deng M; Fridley BL; Kalari KR; Abo RP; Jenkins G; Batzler A; Carlson EE; Barman P; Moran S; Heyn H; Esteller M; Wang L
    Hum Mol Genet; 2016 Nov; 25(21):4819-4834. PubMed ID: 28173075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can pharmacogenetics help rescue drugs withdrawn from the market?
    Shah RR
    Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo mouse models for pharmacogenetic studies.
    Frick A; Suzuki O; Butz N; Chan E; Wiltshire T
    Methods Mol Biol; 2013; 1015():263-78. PubMed ID: 23824862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bayesian hierarchical nonlinear model for assessing the association between genetic variation and drug cytotoxicity.
    Fridley BL; Jenkins G; Schaid DJ; Wang L
    Stat Med; 2009 Sep; 28(21):2709-22. PubMed ID: 19572260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics.
    Low SK; Takahashi A; Mushiroda T; Kubo M
    Clin Cancer Res; 2014 May; 20(10):2541-52. PubMed ID: 24831277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of New Genomic Technologies on Understanding Adverse Drug Reactions.
    Maggo SD; Savage RL; Kennedy MA
    Clin Pharmacokinet; 2016 Apr; 55(4):419-36. PubMed ID: 26369774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic technology applied to pharmacological traits.
    Yang JJ; Plenge RM
    JAMA; 2011 Aug; 306(6):652-3. PubMed ID: 21828330
    [No Abstract]   [Full Text] [Related]  

  • 19. An update on the pharmacogenetics of treating hypertension.
    Fontana V; Luizon MR; Sandrim VC
    J Hum Hypertens; 2015 May; 29(5):283-91. PubMed ID: 25355012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of Drugs Used in the Treatment of Cancers.
    Franczyk B; Rysz J; Gluba-Brzózka A
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.